Optimization of polymerase chain reaction for detection of HIV type 2 DNA.

The aim of this study was to increase the sensitivity of an earlier version of an HIV-2 nested PCR assay based on primers in the gag, pol, LTR, and env regions. The assay was first optimized with regard to concentrations of dNTP, MgCl2, and primers, using a method that allowed optimization of all three parameters in only two test runs. We then designed and optimized new primer sets in the LTR, gag, and gag/pol regions that were based on more isolates than were the former (old) primer sets. Samples from 57 HIV-2 antibody-positive individuals were tested with the four old primer sets as well as with the three new primer sets. Five primer sets from this run (new gag, new gag/pol, old LTR, old env, and new LTR) were then tested with 35 more samples, giving a total number of 92 tested samples from HIV-2-infected individuals. At initial testing of the 92 samples a combination of primer sets from two different regions yielded a sensitivity ranging from 93.5 to 98.9%. After repeated testing the sensitivity ranged from 96.7 to 100% for the different primer combinations. The specificity was 100% for all primer sets except old LTR, which had a specificity of 97%. In conclusion, it is possible to create a more sensitive PCR assay by optimizing the different PCR parameters as well as by including primer sets based on more isolates.

[1]  G. Wadell,et al.  Nested PCR assays with novel primers yield greater sensitivity to Tanzanian HIV-1 samples than a commercial PCR detection kit. , 1996, Journal of virological methods.

[2]  G. Biberfeld,et al.  Nested polymerase chain reaction primers that distinguish between SIVSM and HIV type 2. , 1996, AIDS research and human retroviruses.

[3]  I. Thior,et al.  Natural protection against HIV-1 infection provided by HIV-2. , 1995, Science.

[4]  S. Mboup,et al.  Intrapatient variability of the human immunodeficiency virus type 2 envelope V3 loop. , 1995, AIDS research and human retroviruses.

[5]  G. Satten,et al.  Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors , 1995, Transfusion.

[6]  H Hui,et al.  Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology , 1994, Journal of virology.

[7]  F. Brun-Vézinet,et al.  Cellular and plasma viral load in patients infected with HIV‐2 , 1993, AIDS.

[8]  P. Piot,et al.  Virological and polymerase chain reaction studies of HIV-1/HIV-2 dual infection in Côte d'Ivoire , 1992, The Lancet.

[9]  C. Ou,et al.  Prevalence of HIV-1 and HIV-2 mixed infections in Côte d'Ivoire , 1992, The Lancet.

[10]  M. Reitz,et al.  Genetic variability between isolates of human immunodeficiency virus (HIV) type 2 is comparable to the variability among HIV type 1. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[11]  M. Emerman,et al.  Genome organization and transactivation of the human immunodeficiency virus type 2 , 1987, Nature.

[12]  K. Mullis,et al.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. , 1985, Science.